Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that causes systemic inflammation which can progress to multiorgan failure and death. Symptoms and signs commonly seen in HLH include high fever, hepatosplenomegaly, pancytopenia, and hypertriglyceridemia. This...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2021/7213939 |
_version_ | 1798034325871001600 |
---|---|
author | Albaraa T. Alfaraidi Abdulaziz A. Alqarni Mohammed T. Aqeel Turki A. Albalawi Ahmed S. Hejazi |
author_facet | Albaraa T. Alfaraidi Abdulaziz A. Alqarni Mohammed T. Aqeel Turki A. Albalawi Ahmed S. Hejazi |
author_sort | Albaraa T. Alfaraidi |
collection | DOAJ |
description | Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that causes systemic inflammation which can progress to multiorgan failure and death. Symptoms and signs commonly seen in HLH include high fever, hepatosplenomegaly, pancytopenia, and hypertriglyceridemia. This report describes the 8-month clinical course of a 17-year-old male with G6PD deficiency who presented with intermittent high fever of unknown origin for 8 months accompanied by pancytopenia and bilateral lower limb weakness. A pathogenic homozygous missense mutation (c.1081A > T p.(Arg361Trp)) in the PRF1 gene was detected by whole exome sequencing (WES). The brain and the whole spine MRI showed leptomeningeal enhancement at different levels involving both the brain and the spine. Therefore, a diagnosis of familial HLH type 2 with CNS involvement was confirmed. Accordingly, treatment with dexamethasone, cyclosporin, and etoposide in addition to intrathecal methotrexate and hydrocortisone was given. The patient showed a dramatic response with significant neurological improvement of the bilateral lower limb weakness. Genetic analysis has helped the patient’s family with appropriate genetic counselling. This case highlights the importance of immediate treatment with immunosuppressants and the high clinical suspicion of physicians regarding HLH in areas where consanguinity is common. |
first_indexed | 2024-04-11T20:42:39Z |
format | Article |
id | doaj.art-851356e0724d4b17b9af2856cef02687 |
institution | Directory Open Access Journal |
issn | 2090-6579 |
language | English |
last_indexed | 2024-04-11T20:42:39Z |
publishDate | 2021-01-01 |
publisher | Hindawi Limited |
record_format | Article |
series | Case Reports in Hematology |
spelling | doaj.art-851356e0724d4b17b9af2856cef026872022-12-22T04:04:09ZengHindawi LimitedCase Reports in Hematology2090-65792021-01-01202110.1155/2021/7213939Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 MutationAlbaraa T. Alfaraidi0Abdulaziz A. Alqarni1Mohammed T. Aqeel2Turki A. Albalawi3Ahmed S. Hejazi4College of MedicineCollege of MedicineCollege of MedicineCollege of MedicineDepartment of OncologyHemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that causes systemic inflammation which can progress to multiorgan failure and death. Symptoms and signs commonly seen in HLH include high fever, hepatosplenomegaly, pancytopenia, and hypertriglyceridemia. This report describes the 8-month clinical course of a 17-year-old male with G6PD deficiency who presented with intermittent high fever of unknown origin for 8 months accompanied by pancytopenia and bilateral lower limb weakness. A pathogenic homozygous missense mutation (c.1081A > T p.(Arg361Trp)) in the PRF1 gene was detected by whole exome sequencing (WES). The brain and the whole spine MRI showed leptomeningeal enhancement at different levels involving both the brain and the spine. Therefore, a diagnosis of familial HLH type 2 with CNS involvement was confirmed. Accordingly, treatment with dexamethasone, cyclosporin, and etoposide in addition to intrathecal methotrexate and hydrocortisone was given. The patient showed a dramatic response with significant neurological improvement of the bilateral lower limb weakness. Genetic analysis has helped the patient’s family with appropriate genetic counselling. This case highlights the importance of immediate treatment with immunosuppressants and the high clinical suspicion of physicians regarding HLH in areas where consanguinity is common.http://dx.doi.org/10.1155/2021/7213939 |
spellingShingle | Albaraa T. Alfaraidi Abdulaziz A. Alqarni Mohammed T. Aqeel Turki A. Albalawi Ahmed S. Hejazi Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation Case Reports in Hematology |
title | Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation |
title_full | Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation |
title_fullStr | Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation |
title_full_unstemmed | Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation |
title_short | Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation |
title_sort | familial hemophagocytic lymphohistiocytosis secondary to prf1 mutation |
url | http://dx.doi.org/10.1155/2021/7213939 |
work_keys_str_mv | AT albaraatalfaraidi familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation AT abdulazizaalqarni familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation AT mohammedtaqeel familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation AT turkiaalbalawi familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation AT ahmedshejazi familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation |